Evolution of a contagious cancer: Epigenetic variation in Devil Facial Tumour Disease

Proceedings of the Royal Society B: Biological Sciences

Volumn 280, Issue 1750, 2013, Pages

  Ujvari, Beata ^a   Pearse, Anne Maree ^b   Peck, Sarah ^a,b   Harmsen, Collette ^b   Taylor, Robyn ^b   Pyecroft, Stephen ^b   Madsen, Thomas ^c   Papenfuss, Anthony T ^d,e   Belov, Katherine ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b DEPARTMENT OF PRIMARY INDUSTRIES   (Australia)

^c UNIVERSITY OF WOLLONGONG   (Australia)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cancer; DNA methylation; Epigenetic; Evolution; Marsupial; Tasmanian devil (Sarcophilus harrisii)

Indexed keywords

CANCER; ENZYME ACTIVITY; GENETIC ANALYSIS; HOMEOSTASIS; MARSUPIAL; METHYLATION; MUTATION; PHENOTYPIC PLASTICITY; TUMOR;

EID: 84869795645     PISSN: 09628452     EISSN: 14712954     Source Type: Journal    
DOI: 10.1098/rspb.2012.1720     Document Type: Article

References (61)

1. Lunney D, Jones M, McCallum H. 2008 Lessons from the looming extinction of the Tasmanian devil. Pac. Conserv. Biol. 14, 151-153.
2. Jones ME et al. 2007 Conservation management of Tasmanian devils in the context of an emerging, extinction-threatening disease: devil facial tumor disease. EcoHealth 4, 326-337. (doi:10.1007/ s10393-007-0120-6)
3. McCallum H. 2008 Tasmanian devil facial tumour disease: lessons for conservation biology. Trends Ecol. Evol. 23, 631-637. (doi:10.1016/j.tree. 2008.07.001)
4. Hawkins CE et al. 2006 Emerging disease and population decline of an island endemic, the Tasmanian devil Sarcophilus harrisii. Biol. Conserv. 131, 307-324. (doi:10.1016/j.biocon.2006.04.010)
5. McCallum H, Tompkins DM, Jones M, Lachish S, Marvanek S, Lazenby B, Hocking G, Wiersma J, Hawkins CE. 2007 Distribution and impacts of Tasmanian devil facial tumor disease. EcoHealth 4, 318-325. (doi:10.1007/s10393-007-0118-0)
6. Loh R, Bergfeld J, Hayes D, O'Hara A, Pyecroft S, Raidal S, Sharpe R. 2006 The pathology of devil facial tumor disease (DFTD) in Tasmanian devils (Sarcophilus harrisii). Vet. Pathol. 43, 890-895. (doi:10.1354/vp.43-6-890)
7. Pyecroft SB et al. 2007 Towards a case definition for devil facial tumour disease: what is it? EcoHealth 4, 346-351. (doi:10.1007/s10393-007-0126-0)
8. Pearse AM, Swift K. 2006 Allograft theory: transmission of devil facial-tumour disease. Nature 439, 549. (doi:10.1038/439549a)
9. Obendorf DL, McGlashan ND. 2008 Research priorities in the Tasmanian devil facial tumour debate. Eur. J. Oncol. 13, 229-238.
10. Murchison EP et al. 2010 The Tasmanian devil transcriptome reveals Schwann cell origins of a clonally transmissible cancer. Science 327, 84-87. (doi:10.1126/science.1180616)
11. Loh R, Hayes D, Mahjoor A, O'Hara A, Pyecroft S, Raidal S. 2006 The immunohistochemical characterization of devil facial tumor disease (DFTD) in the Tasmanian devil (Sarcophilus harrisii). Vet. Pathol. 43, 896-903. (doi:10.1354/vp.43-6-896)
12. Belov K. 2011 The role of the major histocompatibility complex in the spread of contagious cancers. Mamm. Genome 22, 83-90. (doi:10.1007/s00335-010-9294-2)
13. Jones ME, Paetkau D, Geffen E, Moritz C. 2004 Genetic diversity and population structure of Tasmanian devils, the largest marsupial carnivore. Mol. Ecol. 13, 2197-2209. (doi:10.1111/j. 1365-294X.2004.02239.x)
14. Siddle HV, Kreiss A, Eldridge MDB, Noonan E, Clarke CJ, Pyecroft S, Woods GM, Belov K. 2007 Transmission of a fatal clonal tumor by biting occurs due to depleted MHC diversity in a threatened carnivorous marsupial. Proc Natl Acad. Sci. USA 104, 16 221-16 226. (doi:10.1073/pnas.0704580104)
15. Siddle HV, Marzec J, Cheng Y, Jones M, Belov K. 2012 MHC gene copy number variation in Tasmanian devils: implications for the spread of a contagious cancer. Proc. R. Soc. B 277, 2001-2006. (doi:10.1098/rspb.2009.2362)
16. Miller W et al. 2011 Genetic diversity and population structure of the endangered marsupial Sarcophilus harrisii (Tasmanian devil). Proc. Natl Acad. Sci. USA 198, 12 348-12 353. (doi:10.1073/ pnas.1102838108)
17. Murchison EP et al. 2012 Genome sequencing and analysis of the Tasmanian devil and its transmissible cancer. Cell 148, 780-791. (doi:10.1016/j.cell.2011. 11.065)
18. Deakin JE et al. 2012 Genomic restructuring in the Tasmanian devil facial tumour: chromosome painting and gene mapping provide clues to evolution of a transmissible tumour. PLoS Genet. 8, e1002483. (doi:10.1371/journal.pgen.1002483)
19. Pearse A-M, Swift K, Hodson P, Hua B, McCallum H, Pyecroft S, Taylor R, Eldridge MDB, Belov K. 2012 Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil population. Cancer Genet. 205, 101-112. (doi:10.1016/j.cancergen.2011.12.001)
20. Gronbaek K, Hother C, Jones PA. 2007 Epigenetic changes in cancer. APMIS 115, 1039-1059. (doi:10. 1111/j.1600-0463.2007.apm_636.xml.x)
21. Sadikovic B, Al-Romaih K, Squire JA, Zielenska M. 2012 Cause and consequences of genetic and epigenetic alterations in human cancer. Curr. Genom. 9, 394-408. (doi:10.2174/ 138920208785699580)
22. Hotchkiss RD. 1948 The quantitative separation of purines, pyrimidines, and nucleosides by paper chromatography. J. Biol. Chem. 175, 315-332.
23. Okano M, Bell DW, Haber DA, Li E. 1999 DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247-257. (doi:10.1016/ s0092-8674(00)81656-6)
24. Wyatt GR. 1951 The purine and pyrimidine composition of deoxypentose nucleic acids. Biochem. J. 48, 584-590.
25. Suzuki MM, Bird A. 2008 DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 9, 465-476. (doi:10.1038/ nrg2341)
26. Herman JG, Baylin SB. 2003 Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349, 2042-2054. (doi:10.1056/NEJMra023075)
27. Jones PA, Baylin SB. 2002 The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415-428.
28. Hermann A, Gowher H, Jeltsch A. 2004 Biochemistry and biology of mammalian DNA methyltransferases. Cell. Mol. Life Sci. 61, 2571-2587. (doi:10.1007/ s00018-004-4201-1)
29. Patra S, Patra A, Rizzi F, Ghosh T, Bettuzzi S. 2012 Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development. Cancer Metastasis Rev. 27, 315-334. (doi:10.1007/s10555-008-9118-y)
30. Wossidlo M, Arand J, Sebastiano V, Lepikhov K, Boiani M, Reinhardt R, Scholer H, Walter J. 2010 Dynamic link of DNA demethylation, DNA strand breaks and repair in mouse zygotes. EMBO J. 29, 1877-1888. (doi:10.1038/emboj.2010.80)
31. Wu SC, Zhang Y. 2010 Active DNA demethylation: many roads lead to Rome. Nat. Rev. Mol. Cell Biol. 11, 607-620. (doi:10.1038/nrm2950)
32. Fan G, Hutnick L. 2005 Methyl-CpG binding proteins in the nervous system. Cell Res. 15, 255-261. (doi:10.1038/sj.cr.7290294)
33. Muller-Tidow C. 2001 Loss of expression of HDACrecruiting methyl-CpG-binding domain proteins in human cancer. Br. J. Cancer 85, 1168-1174. (doi:10.1054/bjoc.2001.2041)
34. Hendrich B, Hardeland U, Ng HH, Jiricny J, Bird A. 2012 The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 401, 301-304. (doi:10.1038/45843)
35. Jones ME, Cockburn A, Hamede R, Hawkins C, Hesterman H, Lachish S, Mann D, McCallum H, Pemberton D. 2008 Life-history change in diseaseravaged Tasmanian devil populations. Proc. Natl Acad. Sci. USA 105, 10 023-10 027. (doi:10.1073/ pnas.0711236105)
36. Vos P et al. 1995 AFLP: a new technique for DNA fingerprinting. Nucleic Acids Res. 23, 4407-4414. (doi:10.1093/nar/23.21.4407)
37. Bensch S, Helbig AJ, Salomon M, Seibold I. 2002 Amplified fragment length polymorphism analysis identifies hybrids between two subspecies of warblers. Mol. Ecol. 11, 473-481. (doi:10.1046/j. 0962-1083.2001.01455.x)
38. Xu M, Li X, Korban S. 2000 AFLP-based detection of DNA methylation. Plant Mol. Biol. Rep. 18, 361-368. (doi:10.1007/BF02825064)
39. Kronforst MR, Gilley DC, Strassmann JE, Queller DC. 2012 DNA methylation is widespread across social Hymenoptera. Curr. Biol. 18, R287-R288. (doi:10.1016/j.cub.2008.02.015)
40. Lo N, Li B, Ujvari B. 2012 DNA methylation in the termite Coptotermes lacteus. Insect Soc. 59, 257-261. (doi:10.1007/s00040-011-0213-7)
41. Rasmussen R. 2001 Quantification on the LightCycler instrument. In Rapid cycle real-time PCR: methods and applications (eds S Meuer, C Wittwer, K Nakagawara), pp. 21-34. Heidelberg, Germany: Springer.
42. Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP. 2012 Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BESTKEEPER-EXCEL-based tool using pairwise correlations. Biotechnol. Lett. 26, 509-515. (doi:10.1023/B:BILE.0000019559.84305.47)
43. Pfaffl MW, Horgan GW, Dempfle L. 2002 Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30, e36. (doi:10.1093/nar/30.9.e36)
44. Excoffier L, Laval G, Schneider S. 2007 ARLEQUIN (v. 3.0): an integrated software package for population genetics data analysis. Evol. Bioinform. 2005, 47-50.
45. Ehrlich M. 2002 DNA methylation in cancer: too much, but also too little. Oncogene 21, 5400-5413. (doi:10.1038/sj.onc.1205651)
46. Shao C, Lacey M, Dubeau L, Ehrlich M. 2009 Hemimethylation footprints of DNA demethylation in cancer. Epigenetics 4, 165-175. (doi:10.4161/epi. 4.3.8277)
47. Yegnasubramanian S et al. 2008 DNA hypomethylation arises later in prostate cancer progression than CpG Island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res. 68, 8954-8967. (doi:10.1158/0008-.can-07-6088)
48. Singer T, McConnell MJ, Marchetto MCN, Coufal NG, Gage FH. 2010 LINE-1 retrotransposons: mediators of somatic variation in neuronal genomes? Trends Neurosci. 33, 345-354. (doi:10. 1016/j.tins.2010.04.001)
49. Rehen SK et al. 2005 Constitutional aneuploidy in the normal human brain. J. Neurosci. 25, 2176-2180. (doi:10.1523/jneurosci.4560-04.2005)
50. Merlo LMF, Pepper JW, Reid BJ, Maley CC. 2006 Cancer as an evolutionary and ecological process. Nat. Rev. Cancer 6, 924-935. (doi:10.1038/nrc2013)
51. Caulin AF, Maley CC. 2011 Petos Paradox: evolutions prescription for cancer prevention. Trends Ecol. Evol. 26, 175-182. (doi:10.1016/j.tree. 2011.01.002)
52. Nowell PC. 1976 The clonal evolution of tumor cell populations. Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression. Science 194, 23-28. (doi:10. 1126/science.959840)
53. Coupland C, Anthony W. 2007 Devils of the alpine project: field monitoring program. Tasmanian Nat. 129, 65-81.
54. Hamede R, Lachish S, Belov K, Woods G, Kreiss A, Pearse A-M, Lazenby B, Jones M, McCallum H. 2012 Reduced effect of Tasmanian devil facial tumor disease at the disease front. Conserv. Biol. 26, 124-134. (doi:10.1111/j.1523-1739.2011.01747.x)
55. Lane A, Cheng Y, Wright B, Hamede R, Levan L, Jones M, Ujvari B, Belov K. 2012 New insights into the role of MHC diversity in devil facial tumour disease. PLoS ONE 7, e36955. (doi:10.1371/journal. pone.0036955)
56. Hsiao YW, Liao KW, Hung SW, Chu RM. 2002 Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells. Vet. Immunol. Immunopathol. 87, 19-27. (doi:10.1016/S0165-2427(02)00026-0)
57. van den Elsen PJ, Holling TM, van der Stoep N, Boss JM. 2003 DNA methylation and expression of major histocompatibility complex class I and class II transactivator genes in human developmental tumor cells and in T cell malignancies. Clin. Immunol. 109, 46-52. (doi:10.1016/s1521-6616(03)00200-6)
58. Fassati A, Mitchison N. 2010 Testing the theory of immune selection in cancers that break the rules of transplantation. Cancer Immunol. Immunother. 59, 643-651. (doi:10.1007/s00262-009-0809-1)
59. Kreiss A, Cheng Y, Kimble F, Wells B, Donovan S, Belov K, Woods GM. 2011 Allorecognition in the Tasmanian devil (Sarcophilus harrisii), an endangered marsupial species with limited genetic diversity. PLoS ONE 6, e22402. (doi:10.1371/journal. pone.0022402)
60. Muotri AR, Marchetto MCN, Coufal NG, Oefner R, Yeo G, Nakashima K, Gage FH. 2010 L1 retrotransposition in neurons is modulated by MeCP2. Nature 468, 443-446. (doi:10.1038/ nature09544)
61. Bruder CEG et al. 2008 Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am. J. Hum. Genet. 82, 763-771. (doi:10.1016/j. ajhg.2007.12.011)